The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index; 12 of the 37 sources its claims cite were checked for support.
One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial.
Open accessAbstract
In patients with migraine, depression is associated with poorer medical prognosis, decreased quality of life, and increased risk of suicidality and disability; yet, behavioral interventions have rarely been investigated. The current study compared the efficacy of two 1-day (5- to 6-h) interventions for co-occurring migraine and depression: (1) acceptance and commitment therapy plus migraine education (ACT-ED), and (2) support plus migraine education (S-ED). One hundred and thirty-six patients with comorbid depression and migraine were randomized to a treatment. One hundred and three (76%) completed the ACT-ED (N = 56) or S-ED (N = 47) workshop. Primary outcomes were depression diagnosis and symptoms. Secondary outcomes were anxiety symptoms, headache-related disability and general functioning, and quality of life. Assessments were completed at baseline and 3 and 6 months following the workshop. At the 6-month follow-up, on categorical outcomes, a significantly greater number of people in the ACT-ED condition no longer met criteria for a major depressive episode and exhibited a > 50% drop in symptoms on the Hamilton Rating Scale of Depression. Similarly, though, weaker results were found when examining depressive symptoms dimensionally. On secondary outcomes, people in the ACT-ED condition exhibited significantly greater improvements in anxiety, headache-related disability, and quality of social relationships, compared to S-ED, No differences between groups were observed in general functioning. A 1-day (5- to 6-h) ACT workshop can deliver substantial and lasting benefits to depressed migraineurs, over and above those provided by group support and education. This approach is an attractive alternative to weekly psychotherapy. Clinicaltrials.gov # NCT02108678.
Overview
CoChat Summary
## TL;DR
This randomized clinical trial compared a 1-day ACT plus migraine education workshop to a 1-day support plus migraine education workshop in 136 patients with comorbid migraine and depression. ACT-ED produced better outcomes for depression response, anxiety, headache-related disability, and some quality-of-life domains, though both groups improved and general functioning did not differ.
## Key findings
- Of 136 randomized participants, 56 attended ACT-ED and 47 attended S-ED; 103 total completed a workshop, and 24% of those randomized did not attend.
- Depression response on the HRSD was higher with ACT-ED: 62.8% vs 35.3% at 3 months (OR = 3.10; NNT = 3.6; p = 0.021), and 51.4% vs 28.2% at 6 months (OR = 2.70; NNT = 3.9; p = 0.059); overall treatment effect F(1,97) = 8.39, p = 0.005.
- Current major depressive episode on SCID-IV was lower with ACT-ED at 6 months: 22.6% vs 45.8% (OR = 0.35, p = 0.044); overall treatment effect F(1,97) = 4.44, p = 0.038.
- Secondary outcomes favored ACT-ED for anxiety and headache disability: SIGH-A response at 6 months was 51.8% vs 20.2% (OR = 4.25; NNT = 3.2; p = 0.014), and HDI decline ≥29 points was 37.7% vs 12.1% at 6 months (OR = 4.40; p = 0.022).
- Quality-of-life improvements were greater for ACT-ED in psychological well-being and social relationships; no significant between-group difference was found for WHO-DAS general functioning.
## Methods
- Randomized controlled trial with blinded assessors; eligible participants with migraine and current major depressive episode were randomly assigned by permuted blocks to ACT-ED or S-ED.
- Sample: 136 eligible participants randomized; 56 attended ACT-ED and 47 attended S-ED. Baseline screening involved 4,880 individuals, and 177 completed in-person assessment.
- Main analysis used generalized linear mixed models and linear mixed models for repeated measures across baseline, 3 months, and 6 months; outcomes included depression, anxiety, headache-related disability, general functioning, and quality of life.
## Limitations
- The paper explicitly states that the longevity of treatment effects “must be empirically investigated,” and recommends follow-up longer than the 6-month period used here.
- The paper explicitly notes future studies should examine effects on migraine-related pain, medication use, and healthcare utilization, implying these were not assessed here.
- Evident from the text: 24% of randomized participants did not attend a workshop, so the attended-workshop sample is smaller than the randomized sample and may limit generalizability to all eligible patients.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
11 Valid · 0 Not valid · 19 Not checked · 69 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Importantly, when presented as a brief intervention , ACT has resulted in positive outcomes [10, 11].”
What the sources say
- Supportedcites [10] Dindo, 2017, Acceptance and commitment therapy: A transdiagnostic behavioral intervention for mental health and medical conditions, Neurotherapeutics source
The section “ACT Interventions can be Brief” reports successful delivery in short formats and describes preliminary efficacy, including fewer sick days and reduced hospitalizations in two studies. The paper cautions that many studies are preliminary and need replication. (LLM, conf=0.94)
- Supportedcites [11] Dindo, 2015, One-day acceptance and commitment training workshops in medical populations, Curr Opin Psychol source
The Discussion reports that one-day ACT interventions in medical populations show promise for reducing distress, improving health behaviors, and optimizing functioning. The Brief ACT Workshops section also reports improved symptoms and quality of life after a one-day intervention, supporting the claim that brief ACT has produced positive outcomes. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, in a small, uncontrolled pilot trial, patients with co-occurring depression and migraine were assigned to a 1-day ACT plus Education (ACT-ED) group workshop or to Treatment as Usual (TAU). Promising results were found with 77% of the participants in the ACT-ED arm remitting from depression compared to only 8% of those in TAU [12].”
What the sources say
- Partly supportedcites [12] Dindo, 2012, One-day behavioral treatment for patients with comorbid depression and migraine: A pilot study, Behav Res Ther sourceExperimental — accuracy not yet measured
The Results (Outcome analyses) report that at 12 weeks, 24/31 ACT-ED participants (77%) no longer met criteria for a major depressive episode, versus 1/13 WL/TAU participants (8%). The Methods (Participants and Assignment) describe a small pilot with a wait-list/treatment-as-usual comparison group, so calling the trial “uncontrolled” is inaccurate. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“First, for patients with functional limitations and practical barriers such as transportation difficulties or family and work responsibilities [36], a 1-day workshop ensures treatment adherence and completion.”
What the sources say
- Partly supportedcites [36] Spleen, 2014, Health care avoidance among rural populations: results from a nationally representative survey, J Rural Health sourceExperimental — accuracy not yet measured
The Discussion (page not available) identifies transportation barriers, and the introductory passage links care avoidance to social and work expectations. The copy does not establish functional limitations or family responsibilities as barriers. Citation [36] is attached to the barriers clause; the statement that a 1-day workshop ensures adherence and completion is the citing authors’ own proposal, not a finding attributed to this source. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with previous ACT research, positive effects on distress and disability were maintained or strengthened at the final 6-month follow-up period [42].”
What the sources say
- Partly supportedcites [42] Luoma, 2012, Slow and steady wins the race: A randomized clinical trial of acceptance and commitment therapy targeting shame in substance use disorders, J Consult Clin Psychol sourceExperimental — accuracy not yet measured
The Results > Secondary Outcomes section reports that ACT participants retained an improvement in general mental health and maintained an improvement in quality of life through follow-up; the quality-of-life measure includes aspects of functional status. But Method > Procedure specifies a 4-month follow-up, not 6 months, and the paper does not report a separate disability outcome. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, the effect sizes are generally higher than those obtained for pharmacological treatment of mild-to-moderate depression [34]”
What the sources say
- Supportedcites [34] Fournier, 2010, Antidepressant drug effects and depression severity: a patient-level meta-analysis, Jama source
The Results (Baseline Severity and Symptom Change in ADM and Placebo) report a drug–placebo effect size of d=.11 for mild-to-moderate depression. This supports the cited pharmacological-treatment benchmark; the comparison with the citing study’s own effect sizes is the citing authors’ conclusion. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
52 more claims · 1 with their cited sources checked
Create a free account to see all 99 claims and every source verdict.
- Probably not a substantial claim. 27
- It may state two separate claims as one. 22
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dindo et al. [104] also reported that participants in their ACT-ED condition exhibited significantly greater improvements in depressive symptoms, general functioning, and migraine-related disability than patients in WL and TAU groups.”
From Effectiveness of acceptance and commitment therapy in central pain sensitization syndromes: A systematic review (2021) · cites this paper as [104]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With respect to quality of life, ACT has been shown to increase quality of life [99,103,104], levels of functioning [103], psychological well-being and the quality of social relationships [104], as well as to reduce disability [99,101,103,104].”
From Effectiveness of acceptance and commitment therapy in central pain sensitization syndromes: A systematic review (2021) · cites this paper as [104]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“No significant mediating effects of gender, race, education, income, or medication use were observed in the ACT-ED or Support plus Education (S-ED) groups [104].”
From Effectiveness of acceptance and commitment therapy in central pain sensitization syndromes: A systematic review (2021) · cites this paper as [104]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“has been successfully implemented in varied delivery formats [14–16], including one-day group workshops [17, 18].”
The cited source says what the claim attributes to it.
In the citing paper
“Regarding emotional variables, ACT seems to reduce affective distress [109], as well as levels of anxiety and depression [99,103,104].”
From Effectiveness of acceptance and commitment therapy in central pain sensitization syndromes: A systematic review (2021) · cites this paper as [104]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- ConsistentF(2, 109) = 2.51reported p = .086 · recomputed p = .086
“F(2, 109) = 2.51, p = .086”
- ConsistentF(2, 92) = 2.92reported p = .059 · recomputed p = .059
“F(2, 92) = 2.92, p = .059”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ WHO-DAS
“Mean WHO-DAS score decreased over time in both the ACTED and ED-S groups, with no significant difference in the magnitude of change over time between the two groups [treatment-by-time interaction F(2, 1.82) = 1.28; p = 0.282].”
§ Discussion
“| Treatment*Time Interaction: F(2,182) =1.28 | Treatment*Time Interaction: F(2,182) =1.28 | Treatment*Time Interaction: F(2,182) =1.28 | | | | | 0.282 |”
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Skevington, S. M., Lotfy, M., & O'Connell, K. A. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000018486.91360.00 · Cited by 4,686
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Wilamowska (2010) · doi:10.1001/archpsyc.1988.01800320058007 · Cited by 2,115
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009
A meta-analysis of psychotherapy dropout
Wierzbicki, M., & Pekarik, G. (1993) · Professional Psychology: Research and Practice · doi:10.1037/0735-7028.24.2.190 · Cited by 1,118
Psychotherapy for depression in adults: A meta-analysis of comparative outcome studies.
Cuijpers, P., van Straten, A., Andersson, G., & van Oppen, P. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0013075 · Cited by 1,050
Holt-Lunstad, J. (2018) · Annual Review of Psychology · doi:10.1146/annurev-psych-122216-011902 · Cited by 873
Efficacy of Interpersonal Psychotherapy for Postpartum Depression
O'Hara, M. W., Stuart, S., Gorman, L. L., & Wenzel, A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1039 · Cited by 662
Research works printed but not linked: 1
- Dindo, 2019, One-day ACT workshops for patients with chronic health problems and associated emotional disorders
Cited by
Psychological Interventions for the Treatment of Chronic Pain in Adults
Driscoll, M. A., Edwards, R. R., Becker, W. C., Kaptchuk, T. J., & Kerns, R. D. (2021) · Psychological Science in the Public Interest · doi:10.1177/15291006211008157 · Cited by 176
New generation psychological treatments in chronic pain
McCracken, L. M., Yu, L., & Vowles, K. E. (2022) · BMJ · doi:10.1136/bmj-2021-057212 · Cited by 123
Ferreira, M. G., Mariano, L. I., Rezende, J. V. D., Caramelli, P., & Kishita, N. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.134 · Cited by 94
Dochat, C., Wooldridge, J. S., Herbert, M. S., Lee, M. W., & Afari, N. (2021) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2021.03.003 · Cited by 60
“Of nine effects, five were from the WHODAS (Dindo et al., 2012; Huddleston et al., 2018; Pedersen et al., 2019; Dindo et al., 2020a; Dindo et al., 2020b), one was from WHO-QoL-BREF (Dindo et al., 2015), one was from the Quality of Life Inventory (Sheppard et al., 2010), and two were from measures…”
BackgroundMethodInfluentialGalvez-Sánchez, C. M., Montoro, C. I., Moreno-Padilla, M., Reyes del Paso, G. A., & de la Coba, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122706 · Cited by 45
“Fibromyalgia Syndrome First Author (Publication Year), Study Name, Country Study Design/ Diagnostic Technique Sample Size, Age (Mean ± SD) Period and Treatment Characteristics Variables and Results Dindo et al., 2020.”
BackgroundMethodResultInfluential
Metadata
- Authors
- Dindo, L. N., Recober, A., Calarge, C. A., Zimmerman, B. M., Weinrib, A., Marchman, J. N., & Turvey, C.
- Affiliations
- Michael E. DeBakey VA Medical Center (US)
- Children's Hospital of Philadelphia (US)
- Baylor College of Medicine (US)
- University of Iowa (US)
- University Health Network (CA)
- Corresponding author
- Dindo, Lilian N.
- Venue
- Neurotherapeutics
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 17
- Issue
- 2
- Pages
- 743-753
- ISSN
- 1878-7479 (ISSN-L)
- PMC
- PMC7283406
- OpenAlex
- W2994970239
- Semantic Scholar
- 0c37aba1e296d91c195ab96ffb7730437f8e3225
- Cited by
- 24
- References
- 45
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 6
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1234 d)
- Locations
- Neurotherapeutics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (K23MH097827)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- acceptance and commitment therapy, migraine, depression, group support, brief psychotherapy, headache-related disability, anxiety, quality of life, social functioning
- MeSH terms
- Adult, Depression, Female, Humans, Male, Middle Aged, Migraine Disorders, Patient Education as Topic, Psychotherapy, Group, Treatment Outcome, Acceptance and Commitment Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial. https://app.cochat.ai/papers/10.1007/s13311-019-00818-0
- The paper
- Dindo, L. N., Recober, A., Calarge, C. A., Zimmerman, B. M., Weinrib, A., Marchman, J. N., & Turvey, C. (2020). One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial. Neurotherapeutics. https://doi.org/10.1007/s13311-019-00818-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.